DSCOY
Daiichi Sankyo
Phase 3
Estimated
Ifinatamab deruxtecan
Small Cell Lung Cancer
T-minus 297 days
Apr 30, 2027
ClinicalTrials.gov
verified 15h ago
Countdown card →